Differential expression of angiogenic cytokines by cell lines and primary cultures of human prostate cancer

被引:6
作者
Dall'Era, MA
Shih, SJ
Yang, J
Benik, S
Gandour-Edwards, R
Evans, CP
机构
[1] Univ Calif Davis, Sch Med, Dept Urol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, Sch Med, Dept Pathol, Sacramento, CA 95817 USA
关键词
basic fibroblast growth factor; vascular endothelial growth factor; tumor necrosis factor alpha; urokinase; primary prostate culture;
D O I
10.1038/sj.pcan.4500515
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on angiogenic cytokines usually are initially based upon their expression by available established cell lines. Our hypothesis is that established epithelial prostate cancer (CaP) cell lines do not accurately reflect angiogenic cytokine expression as compared to epithelial and stromal components of primary cultures generated from clinical CaP specimens. Serum free and growth factor free conditioned medium (CM) was collected from PC3, LNCaP, and their orthotopic selected prostate cancer sublines. Surgically acquired and pathologically confirmed neoplastic prostate tissue was selectively grown for selection of epithelial or stromal components, and CM was also collected. CM was assayed for urokinase (u-PA), basic fibroblast growth factor (bFCF), vascular endothelial growth factor (VEGF), and tumor necrosis factor alpha (TNF-ol). u-PA was expressed only by androgen independent cell lines, but was detectable in the epithelial and stromal cultures of androgen sensitive primary cultures. bFGF was not secreted by cell lines nor epithelial primary cultures. VEGF was universally expressed, but TNF-alpha was not secreted by cells lines nor primary cultures. These data suggest that the expression of angiogenic cytokines by established epithelial Cap cell lines does not reflect epithelial and stromal primary cultures.
引用
收藏
页码:106 / 111
页数:6
相关论文
共 36 条
[1]   MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS [J].
AUSPRUNK, DH ;
FOLKMAN, J .
MICROVASCULAR RESEARCH, 1977, 14 (01) :53-65
[2]  
Balbay MD, 1999, CLIN CANCER RES, V5, P783
[3]   PLASMINOGEN ACTIVATORS, TISSUE DEGRADATION, AND CANCER [J].
DANO, K ;
ANDREASEN, PA ;
GRONDAHLHANSEN, J ;
KRISTENSEN, P ;
NIELSEN, LS ;
SKRIVER, L .
ADVANCES IN CANCER RESEARCH, 1985, 44 :139-266
[4]  
DVORAK HF, 1995, AM J PATHOL, V146, P1029
[5]  
Evans CP, 1997, CANCER RES, V57, P3594
[6]   Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells [J].
Ferrer, FA ;
Miller, LJ ;
Andrawis, RI ;
Kurtzman, SH ;
Albertsen, PC ;
Laudone, VP ;
Kreutzer, DL .
JOURNAL OF UROLOGY, 1997, 157 (06) :2329-2333
[7]   INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA [J].
FOLKMAN, J ;
WATSON, K ;
INGBER, D ;
HANAHAN, D .
NATURE, 1989, 339 (6219) :58-61
[8]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[9]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[10]   TUMOR-NECROSIS-FACTOR TYPE-ALPHA, A POTENT INHIBITOR OF ENDOTHELIAL-CELL GROWTH-INVITRO, IS ANGIOGENIC INVIVO [J].
FRATERSCHRODER, M ;
RISAU, W ;
HALLMANN, R ;
GAUTSCHI, P ;
BOHLEN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (15) :5277-5281